Eagle Pharmaceuticals, Inc. company logo
Eagle Pharmaceuticals, Inc. logo

Eagle Pharmaceuticals, Inc. (EGRX) Depreciation & Amortization

Annual D&A

$13.27M$8.46M+176.05%

Summary

Current Value
As of today, EGRX annual D&A is $13.27M, up +176.05% on
Historical Performance
EGRX annual D&A is up +185.25% over the past 3 years, and up +254.07% over the past 5 years
All-Time High Comparison
EGRX annual D&A is currently at its all-time high
3-Year Low Comparison
EGRX annual D&A is at its 3-year low
Sector Comparison
EGRX annual D&A is higher than 75.54% of companies in Healthcare sector

Depreciation & Amortization Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

EGRX Performance
MetricDateValue1Y3Y5Y15Y
Annual D&A$13.27M+176.1%+185.3%+254.1%+4772.2%
Quarterly D&A$5.90M+204.3%+423.5%+496.7%
TTM D&A$21.92M+288.4%+371.4%+463.4%
$0.25-79.0%-99.2%-99.5%
Annual SG&A$106.63M+41.6%+39.6%+49.3%+2238.2%
Annual Total Expenses$280.97M+55.9%+54.7%+52.1%+1814.4%
Annual Operating Expenses$127.47M+0.7%+12.6%+22.9%+863.2%
Annual Revenue$316.61M+84.6%+61.6%+33.8%+3223.7%

Depreciation & Amortization Highs

EGRX Annual D&A Highs Comparison
PeriodHighDateCurrent
3Y$13.27MN/Aat high
5Y$13.27Mat high
All$13.27Mat high

Depreciation & Amortization Lows

EGRX Annual D&A Lows Comparison
PeriodLowDateCurrent
3Y$13.27MN/Aat low
5Y$4.77MN/A+178.4%
All$13.00K>+9999.0%

Depreciation & Amortization History

YearValueChange
$13.27M+176.1%
$4.81M+0.8%
$4.77M+2.5%
$4.65M+26.7%
$3.67M-2.1%
$3.75M+135.8%
YearValueChange
$1.59M+1,318.8%
$112.00K+761.5%
$13.00K-90.4%
$135.00K-43.8%
$240.20K-11.8%
$272.30K-

FAQ

  • What is the current annual D&A of EGRX?

    As of today, EGRX annual D&A is $13.27M

  • What is 1-year change in EGRX annual D&A?

    EGRX annual D&A is up +176.05% year-over-year

  • What is 3-year change in EGRX annual D&A?

    EGRX annual D&A is up +185.25% over the past 3 years

  • How far is EGRX annual D&A from its all-time high?

    EGRX annual D&A is currently at its all-time high

  • How does EGRX annual D&A rank versus sector peers?

    EGRX annual D&A is higher than 75.54% of companies in Healthcare sector

  • When is EGRX next annual earnings release?

    As of today, the next annual earnings release for EGRX has not been scheduled

Data Sources & References

  1. EGRX Official Website www.eagleus.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/827871/000082787123000024/0000827871-23-000024-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/827871/000082787123000009/0000827871-23-000009-index.htm
  4. EGRX Profile on Yahoo Finance finance.yahoo.com/quote/EGRX
  5. EGRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/egrx